C. De Bruyn

549 total citations · 1 hit paper
22 papers, 364 citations indexed

About

C. De Bruyn is a scholar working on Molecular Biology, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, C. De Bruyn has authored 22 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Obstetrics and Gynecology. Recurrent topics in C. De Bruyn's work include Biochemical and Molecular Research (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Uterine Myomas and Treatments (5 papers). C. De Bruyn is often cited by papers focused on Biochemical and Molecular Research (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Uterine Myomas and Treatments (5 papers). C. De Bruyn collaborates with scholars based in Belgium, Netherlands and Italy. C. De Bruyn's co-authors include T. Van den Bosch, D. Timmerman, Nathalie Meuleman, Basile Stamatopoulos, Robert A. de Leeuw, Judith A.F. Huirne, Frank Oerlemans, Wouter J.K. Hehenkamp, J. Naftalin and T. Bourne and has published in prestigious journals such as Advances in experimental medicine and biology, Cancers and Ultrasound in Obstetrics and Gynecology.

In The Last Decade

C. De Bruyn

21 papers receiving 353 citations

Hit Papers

Consensus on revised definitions of Morphological Uterus ... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. De Bruyn Belgium 10 172 145 85 83 51 22 364
Marcin Jędryka Poland 11 167 1.0× 101 0.7× 59 0.7× 81 1.0× 71 1.4× 34 303
Heng Cui China 15 394 2.3× 215 1.5× 94 1.1× 140 1.7× 67 1.3× 47 545
Long Kwei United States 8 73 0.4× 62 0.4× 48 0.6× 52 0.6× 62 1.2× 16 215
Audrey P. Garrett United States 9 269 1.6× 230 1.6× 72 0.8× 18 0.2× 77 1.5× 15 467
Frauke Ringel Germany 11 35 0.2× 44 0.3× 59 0.7× 135 1.6× 42 0.8× 24 291
Pia Suvitie Finland 11 435 2.5× 243 1.7× 61 0.7× 125 1.5× 32 0.6× 20 568
Maria-Eulalia Fernández-Montolí Spain 12 117 0.7× 126 0.9× 42 0.5× 42 0.5× 49 1.0× 22 293
Alessia Romito Italy 11 209 1.2× 47 0.3× 98 1.2× 34 0.4× 118 2.3× 19 394
Apostolos C Ziogas Greece 5 51 0.3× 45 0.3× 122 1.4× 96 1.2× 148 2.9× 32 315
Ya-Li Zhai Japan 10 133 0.8× 217 1.5× 68 0.8× 35 0.4× 47 0.9× 11 362

Countries citing papers authored by C. De Bruyn

Since Specialization
Citations

This map shows the geographic impact of C. De Bruyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. De Bruyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. De Bruyn more than expected).

Fields of papers citing papers by C. De Bruyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. De Bruyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. De Bruyn. The network helps show where C. De Bruyn may publish in the future.

Co-authorship network of co-authors of C. De Bruyn

This figure shows the co-authorship network connecting the top 25 collaborators of C. De Bruyn. A scholar is included among the top collaborators of C. De Bruyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. De Bruyn. C. De Bruyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruyn, C. De, Cristina Taliento, Anne‐Sophie Van Rompuy, et al.. (2024). Central necrosis in uterine sarcoma. Ultrasound in Obstetrics and Gynecology. 64(6). 716–720. 1 indexed citations
2.
Laganà, Antonio Simone, Andrea Romano, Arne Vanhie, et al.. (2024). Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper. Gynecologic and Obstetric Investigation. 89(2). 73–86. 5 indexed citations
3.
Bruyn, C. De, Jolien Ceusters, Wouter Froyman, et al.. (2023). Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study. Ultrasound in Obstetrics and Gynecology. 63(5). 683–690. 6 indexed citations
4.
Juffermans, Lynda J.M., Robert A. de Leeuw, C. De Bruyn, et al.. (2022). How to use power Doppler ultrasound in transvaginal assessment of uterine fibroids. Ultrasound in Obstetrics and Gynecology. 60(2). 277–283. 15 indexed citations
5.
Bruyn, C. De, Jolien Ceusters, C. Landolfo, et al.. (2021). Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer. Cancers. 13(23). 5899–5899. 9 indexed citations
6.
Baert, Thaïs, Mattéo Riva, C. De Bruyn, et al.. (2021). Type of chemotherapy has substantial effects on the immune system in ovarian cancer. Translational Oncology. 14(6). 101076–101076. 15 indexed citations
7.
Harmsen, Marissa J., T. Van den Bosch, Robert A. de Leeuw, et al.. (2021). Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound in Obstetrics and Gynecology. 60(1). 118–131. 149 indexed citations breakdown →
8.
Bruyn, C. De, Thaïs Baert, T. Van den Bosch, & An Coosemans. (2020). Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?. Current Oncology Reports. 22(2). 12–12. 7 indexed citations
9.
Mannaerts, Dominique, et al.. (2017). OP17.09: Flow mediated dilation and peripheral arterial tonometry are disturbed in pre‐eclampsia and reflect different aspects of endothelial function. Ultrasound in Obstetrics and Gynecology. 50(S1). 104–105. 1 indexed citations
10.
Bruyn, C. De, et al.. (2014). Identification of peripartum near-miss for perinatal audit.. PubMed. 6(4). 177–83. 3 indexed citations
13.
Stamatopoulos, Basile, Benjamin Haibe‐Kains, Carole Equeter, et al.. (2009). Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica. 94(6). 790–799. 24 indexed citations
14.
Joosten, E.M.G., Coen A. M. van Bennekom, Frank Oerlemans, et al.. (1984). Myoadenylate Deaminase Deficiency: An Enzyme Defect in Search of a Disease. Advances in experimental medicine and biology. 165 Pt A. 85–89. 6 indexed citations
15.
Oerlemans, Frank, et al.. (1981). Isotachophoresis of urinary purines and pyrimidines: the use of spacers and enzymes for identification.. PubMed. 225(2). 369–79. 8 indexed citations
16.
Oerlemans, Frank, et al.. (1981). Metabolite profiling of human muscle extracts by isotachophoresis. Journal of Inherited Metabolic Disease. 4(1). 109–110. 5 indexed citations
17.
Oerlemans, Frank, et al.. (1981). Isotachophoresis of urinary purines and pyrimidines. Journal of Chromatography B Biomedical Sciences and Applications. 225(2). 369–379. 9 indexed citations
18.
Gausset, P, et al.. (1980). Differential responses to mitogen stimulation in lymphocytes from normal individuals and Lesch-Nyhan patients: influence of the bicarbonate buffer system.. PubMed Central. 42(2). 294–302. 1 indexed citations
19.
Oerlemans, Frank, et al.. (1980). Determination of Uric Acid in Serum: Comparison of a Standard Enzymatic Method and Isotachophoresis. Advances in experimental medicine and biology. 122B. 435–440.
20.
Hamet, M., et al.. (1977). A Second Case of Inosine Phosphorylase Deficiency with Severe T-Cell Abnormalities. PubMed. 76A. 477–480. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026